两年一次乳腺X线筛查召回后诊断检查的院间差异:一项基于人群的研究
该回顾性分析利用前瞻性数据库纳入2009至2019年荷兰国家筛查项目中17809名因可疑乳腺X线异常被召回医院的女性,比较不同医院的诊断检查策略。各医院活检使用率36.7%至48.7%(p < 0.001),问题解决MRI使用率2.1%至6.9%(p < 0.001),校正患者和肿瘤特征后差异仍存在;延迟乳腺癌诊断比例2.7%至6.1%(p = 0.07)。作者认为差异虽具统计学显著性但绝对值小,临床影响似乎有限。
要点
- 召回后各医院活检使用率36.7%至48.7%(p < 0.001),问题解决MRI使用率2.1%至6.9%(p < 0.001)。
- 校正患者和肿瘤特征后,院间诊断检查差异仍存在。
- 延迟乳腺癌诊断比例各医院2.7%至6.1%(p = 0.07),差异未达统计学显著。
核心结论
- 在该筛查区域内,两年一次乳腺X线筛查召回后的诊断检查策略存在院间差异,差异虽具统计学显著性但绝对值小,临床影响似乎有限。
研究设计与样本
- 回顾性分析,利用前瞻性获取的数据库,纳入2009至2019年荷兰国家筛查项目中17809名因可疑乳腺X线异常被召回医院的女性,比较不同医院的诊断检查(如额外影像检查类型和频率及活检),并用多变量分析校正混杂因素。
诊断标准与关键数值
- 活检使用率各医院间为36.7%至48.7%(p < 0.001)。
- 问题解决MRI使用率各医院间为2.1%至6.9%(p < 0.001)。
- 延迟乳腺癌诊断(召回或医院首次分析后超过三个月组织病理学确诊乳腺癌)比例各医院间为2.7%至6.1%(p = 0.07)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Quality control in breast cancer screening programmes has been subject of several studies. However, less is known about the clinical diagnostic work-up in recalled women with a suspicious finding at screening mammography. The current study focuses on interhospital differences in diagnostic work-up strategies.
MATERIALS AND METHODS: In this retrospective analysis, using a prospectively obtained database, we included 17,809 women who participated in the Dutch national screening programme between 2009 and 2019 and were recalled to a hospital for analysis of a suspicious mammographic abnormality. The diagnostic work-up (e.g., type and frequency of additional imaging and biopsy) in the different hospitals were compared and analysed by multivariable analysis to correct for confounders.
RESULTS: Use of biopsy varied from 36.7% to 48.7% (p < 0.001) between hospitals, and the use of problem-solving magnetic resonance imaging (MRI) from 2.1% to 6.9% (p < 0.001). These interhospital differences remained after correction for patients and tumour characteristics. The percentage of women with a delayed breast cancer diagnosis, defined as histopathological confirmation of breast cancer more than three months after recall or first analysis in the hospital, varied from 2.7% to 6.1% between hospitals (p = 0.07).
CONCLUSIONS: In our screening region interhospital differences were observed in diagnostic work-up following recall at biennial screening mammography. Though statistically significant, absolute differences were small, and therefore, their clinical impact appears to be limited.
KEY POINTS: Question It is unclear how diagnostic work-up strategies vary between hospitals for women recalled after suspicious findings in breast cancer screening. Findings Significant differences in biopsy techniques and the use of problem-solving MRI were observed, though the clinical impact of these variations is likely to be marginal. Clinical relevance Evaluation of interhospital variation in the diagnostic work-up strategies after recall may aid in optimising the quality of breast cancer care and, indirectly, the effectiveness of the screening programme.
引用
- van der Veer EL, Rozemond F, Generaal MI, et al. Interhospital variations in diagnostic work-up following recall at biennial screening mammography-a population-based study. Eur Radiol. 2024. PMID: 39708083. doi:10.1007/s00330-024-11302-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。